Is GATA3 expression maintained in regional metastases?: A study of paired primary and metastatic urothelial carcinomas

American Journal of Surgical Pathology

Volumn 37, Issue 12, 2013, Pages 1876-1881

  Zhao, Lei ^a   Antic, Tatjana ^a   Witten, Daniela ^b   Paner, Gladell P ^a   Taxy, Jerome B ^a   Husain, Aliya ^a   Gwin, Katja ^a   Mirza, M Kamran ^a   Lingen, Mark W ^a   Tretiakova, Maria S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

GATA3; mimickers; primary and metastatic; urothelial carcinoma

Indexed keywords

TRANSCRIPTION FACTOR GATA 3; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84888129675     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31829e2525     Document Type: Article

References (17)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29
2. Eble JN, Sauter G, Epstein J, Sesterhenn J. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004
3. Parker DC, Folpe AL, Bell J, et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol. 2003;27:1-10
4. Liu H, Shi J, Wilkerson ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: A useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol. 2012;138:57-64
5. Chang A, Amin A, Gabrielson E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012;36: 1472-1476
6. Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31:673-680
7. Miyamoto H, Izumi K, Yao JL, et al. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol. 2012;43:2033-2040
8. Raspollini MR, Sardi I, Giunti L, et al. Plasmacytoid urothelial carcinoma of the urinary bladder: Clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series. Hum Pathol. 2011;42:1149-1158
9. Kouros-Mehr H, Slorach EM, Sternlicht MD, et al. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041-1055
10. Gulmann C, Paner GP, Parakh RS, et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol. 2013;44:164-172
11. Villa C, Zhu B, Luan C, et al. GATA3 expression alteration in high grade and high stage urothelial carcinoma. Mod Pathol. 2013;26(suppl 2):254A.
12. Warrick J, Palanisam N, Siddiqui J, et al. GATA3 expression in nested, micropapillary, and plasmacytoid urothelial carcinomas. Mod Pathol. 2013;26(suppl 2):256A.
13. Rao Q, Williamson SR, Lopez-Beltran A, et al. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: Extended immunohistochemical profiles emphasizing novel markers. Mod Pathol. 2013;26:725-732
14. Ellis C, Chang A, Cimino-Mathews A, et al. GATA3 is a useful marker for signet ring adenocarcinoma of the urinary bladder. Mod Pathol. 2013;26(suppl 2):208A.
15. Chang A, Brimo F, Montgomery EA, et al. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Hum Pathol. 2013. [Epub ahead of print
16. Raspollini MR, Comin CE, Crisci A, et al. The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung. Pathologica. 2010;102:33-35
17. Esheba GE, Longacre TA, Atkins KA, et al. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Am J Surg Pathol. 2009;33:347-353